BioJapan 2023

Presentation Abstract

CETSA® by Pelago Bioscience is a well-proven, best-in-class technology used to assess cellular protein-compound binding in cell. CETSA® can be applied throughout all steps of the drug discovery value chain for screening, hit confirmation and selectivity.

Because neither the ligand nor the protein is modified, CETSA® provides reliable measurements of target engagement in authentic cellular environments and under actual physiological conditions.

We are delighted to share that we will be taking part in the upcoming BioJapan 2023. We have made the necessary preparations, which include the following:

    • Exhibitin booth (B-80)
    • 30 min presentation
    • Our team of experts

We eagerly anticipate the opportunity to meet you at the conference.

Submit the form and book a time with one of our representatives.